Metacognitive Therapy Compared to Cognitive-behavioral Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKarolinska Institutet
About this trial
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older,
A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
No change in dose during the last six weeks if on pharmacological treatment, and
Ability to read and speak Swedish.
Disqualifiers
A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
Acute suicide risk, or
Concurrent psychological treatment.
Trial design
Design model
Parallel
Treatments tested in this trial
Transdiagnostic metacognitive therapy
BehavioralMetacognitive therapy focuses on metacognitions.
Disorder-specific cognitive-behavioral therapy
BehavioralCognitive-behavioral therapy focuses on cognitions and/or behaviors.
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Transdiagnostic metacognitive therapyExperimental treatment 1 intervention
Group B: Disorder-specific cognitive-behavioral therapyActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Qualitative interview data
Participant responses based on questions posed in an interview
Time frame
Up to 13 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov